Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
'This stock is only going up from here imho I wouldn’t be surprised if we get those double digits again within a year or two with flows and production underway.' TYB 10th feb 21 . price was 1.325 or 13.25 in todays money. Maybe the reason they didnt sell at 1.5 TYB is cos you persuaded them not too and because you are a genius, albeit self proclaimed, they believed you. Reality = nearly 3 years later , down over 75% to a price below your lowest ever purchase price... . genius.
Its admirable that you advertise that this company has a history of losing investors money. well done.
'Guys the bottom reached 2 weeks ago and now 3-3.5 will be the holding price until there is good news. All the sellers have sold all bad news out of the way and a whiff of good news and the price will go straight back up from here.' TYB 6th NOV.
He truly is NOT.....radamus.
TYB mentions Azer more than anyone on this board. Why someone that is allegedly pro ZEN would persist in highlighting a previous failure to new prospective punters is beyond me.
Newcastle is a great place to sell alcohol therefore the success of my off licence with Mr Bean as manager is guaranteed. I know he has managed a string of failures but this is different....because its in newcastle.
Big week coming up with vevan deciding on their business plan.
The usual process would be to have a pre ind submission meeting with the FDA. Sulforaphane is naturally created within us so I doubt it will be rejected by fda on risk from chemistry, especially with the phase 1 trials of SFX01 completed and all the data available from evgen. Stalicla will need to agree the protocols for the trial. Once they submit the application its 30 days for fda response. The main issue imo is stalicla deciding to delay the STP2 trial to focus on STP1. But everything I have read says they expect to enter both trials this year.
This is about to get interesting.........
At the moment I feel as though I am in a taxi being taken from from London to Bristol via edinburgh because the Driver likes driving and he is on the meter.
This is what annoys my about the BoD. They seem transfixed by the science.
Science can have many uses and benefits but a listed company exists for one reason only - to make money for shareholders.
Huw needs to stop focusing on being a doctor and focus on being a CEO, the science is just a means to an end.
Evgen arent submitting the application .
Stalicla are submitting it.
They required the data from evgen for their application but other than that it is out of evgens hands.
Here is a question I have been musing. Could the way forward include a PARTIAL development and an ECT claim?
Surely if the LU decision is overturned but there are restrictions placed on what can be developed on the licence there is still ground for a claim.
I see you are still bashing those keys hoping something intelligent is produced.
You cling onto ER's judgement as though it is final.
You do that because it is what you want to happen.
However, in the real human world outside of your egocentric mind, decisions get challenged. As an example have you not noticed how LG has legally challenged the decision of the BEY board?
The same could happen to ER via a judicial review or via pressure from other ministers when the scale of the claim is known. The DECC have indicated they would be open to discussion.
Probably a bit too early to gloat.
Something will have to go disastrously wrong for Evgen not to receive the $5m from stalicla associated with the IND.
IMO stalicla will already be in discussions with the FDA now that they have the data from Evgen.
Please tell me that you meant squib Alf.
Nice prediction.
non of the other forecasts have come true.
Not a single one.
please tell us the current ZEN production.
I will pop back in a few months to check on 'progress'.
Nearly 4 weeks to RNS the start of a study.
Think that says it all really.
Its not exactly dynamic leadership is it.
Was interested why the recent board changes were both noted as interim. The new cfo left his previous company.
why interim
Brutal assessment but sometimes I do get the feeling that the management are transfixed by the biology when their primary focus should be on money.
Not sure I fully agree with that king alf. Every day is a reset. His decisions will be based on where he thinks it is going from this point forwards. However I do think you are right about a spike being due.
The chimp is working himself into a frenzy, throwing excrement at passers - by.
The posting times would lead me to deduce a location somewhere in the equatorial forests of Western Uganda. Very green there. Very, very, very, green.